Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 238 in total
| Status | Patent |
|---|---|
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 5 Sep 2025 Issue date: 23 Nov 2021 |
Application | Utility: High Concentration VEGF Receptor Fusion Protein Containing Formulations Filling date: 5 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: NOVEL IL10 AGONISTS AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) Variants And Uses Thereof Filling date: 5 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN Filling date: 5 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: VIRAL CLEARANCE BY LOW PH HOLD Filling date: 5 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS AND CANCER Filling date: 5 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: Kelch Domain Containing 7B (KLHDC7B) Variants And Uses Thereof Filling date: 5 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: Methods for determining cell killing by a human therapeutic Filling date: 5 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: EFFICIENT SELECTIVITY OF RECOMBINANT PROTEINS Filling date: 5 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION Filling date: 5 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VEGF Filling date: 5 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: NEUTRALIZING ANTIBODY ASSAY FOR THERAPEUTIC PROTEINS Filling date: 5 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: ANTI-GITR ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 4 Nov 2021 |
Grant | Utility: Medical device packaging and related methods Filling date: 5 Sep 2025 Issue date: 2 Nov 2021 |
Application | Utility: SERUM-FREE CELL CULTURE MEDIUM Filling date: 5 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS Filling date: 5 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: DEVICES AND METHODS FOR PRECISION DOSE DELIVERY Filling date: 5 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: METHODS AND SYSTEMS FOR ANALYSIS OF RECEPTOR INTERACTION Filling date: 5 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED B-CELL ACTIVATING FACTOR GENE Filling date: 5 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: PROTEIN-ANTIVIRAL COMPOUND CONJUGATES Filling date: 5 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: HYDROPHILIC LINKERS FOR ANTIBODY DRUG CONJUGATES Filling date: 5 Sep 2025 Issue date: 28 Oct 2021 |
Grant | Design: Packaging Filling date: 5 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: GPR156 variants and uses thereof Filling date: 5 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof Filling date: 5 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof Filling date: 5 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 5 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 5 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: NON-HUMAN ANIMALS MODELS OF RETINOSCHISIS Filling date: 5 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: METHODS FOR CHARACTERIZING LOW-ABUNDANCE HOST CELL PROTEINS Filling date: 5 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: TARGETED MODIFICATION OF RAT GENOME Filling date: 5 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: Fascin-2 (FSCN2) Variants And Uses Thereof Filling date: 5 Sep 2025 Issue date: 30 Sep 2021 |
Grant | Design: Auto-injector cap Filling date: 5 Sep 2025 Issue date: 28 Sep 2021 |
Grant | Utility: Multispecific antigen-binding molecules and uses thereof Filling date: 5 Sep 2025 Issue date: 28 Sep 2021 |
Application | Utility: MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS Filling date: 5 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: METHODS AND SYSTEMS FOR DETERMINING RESPONDERS TO TREATMENT Filling date: 5 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: TARGET INTERFERENCE MITIGATION IN ANTI-DRUG ANTIBODY ASSAY Filling date: 5 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: METHODS FOR DE NOVO PROTEIN SEQUENCING Filling date: 5 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors Filling date: 5 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR SENSITIZATION OF TUMOR CELLS TO IMMUNE THERAPY Filling date: 5 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: A RODENT MODEL OF B4GALT1-MEDIATED FUNCTIONS Filling date: 5 Sep 2025 Issue date: 9 Sep 2021 |
Grant | Utility: Methods for scarless introduction of targeted modifications into targeting vectors Filling date: 5 Sep 2025 Issue date: 7 Sep 2021 |
Application | Utility: METHODS FOR QUANTITATING INDIVIDUAL ANTIBODIES FROM A MIXTURE Filling date: 5 Sep 2025 Issue date: 2 Sep 2021 |
Showing 150 to 200 of 238 patents.